Effect of Either Oral Contraceptive Alone or Associated With Spironolactone on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome.
Phase of Trial: Phase III
Latest Information Update: 28 Mar 2012
At a glance
- Drugs Ethinylestradiol/chlormadinone (Primary) ; Spironolactone (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 21 Jul 2010 Actual patient number is 75 according to ClinicalTrials.gov.
- 17 Feb 2009 New trial record